- San Francisco, CA-based Invuity (NASDAQ:IVTY) is set for its IPO of 4M shares of common stock at $14 - 16.
- The commercial stage medical technology firm develops devices that provide surgeons with improved direct visualization of surgical cavities during minimally invasive surgical procedures. Its technology platform, Intelligent Photonics, is integrated into retractor systems, handheld devices and intracavity drop-in illuminators that direct and shape light into broad, uniform, thermally cool illumination in surgical cavities. According to the company, improving surgeons' ability to see critical anatomical structures improves outcomes and patient safety while reducing surgical time and healthcare costs.
- 2014 Financials ($M): Revenue: 13.1 (+82.3%); Gross Profit: 8.2 (+68.3%); Operating Expenses: 28.0 (+66.1%); Net Loss: (20.7) (-70.6%); CF Ops: (19.8) (-42.6%).